Loading the catalog…
Loading the catalog…
迈威生物拟向全资子公司联威创元增资 8.25 亿元,并以 8.26 亿元向其转让 TCE 项目相关资产,同时联威创元拟引入 5 名投资人合计增资 1.6 亿元,交易完成后迈威生物预计持有联威创元 71.21% 股权,仍为其控股股东。
What RADAR observed and classified to build this opportunity. It is what the source published, not a verification that the offer is still active.
迈威生物:拟向联威创元增资 8.25 亿元并转让 TCE 项目资产. 迈威生物拟向全资子公司联威创元增资 8.25 亿元,并以 8.26 亿元向其转让 TCE 项目相关资产,同时联威创元拟引入 5 名投资人合计增资 1.6 亿元,交易完成后迈威生物预计持有联威创元 71.21% 股权,仍为其控股股东。
Open sourceThe catalog shows persisted RADAR opportunities. Storage availability does not mean sources are verified or offers are active.